Skip to main content
All lobbying firms

RK STRATEGIES, INC.

Registrant on federal lobbying filings · filed 2025 to 2026

$560,000 Income reported
10 Clients represented
54 Filings counted
0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. Everything on this page is grouped by the registrant's LDA id (401107835), not by name.

 Clients 10
 Reported by year 2 years
  • 2026 $190,000 19 filings
  • 2025 $370,000 35 filings
 Issues lobbied 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 7
  • HOUSE OF REPRESENTATIVES 51
  • SENATE 51
  • Health & Human Services, Dept of (HHS) 20
  • Defense, Dept of (DOD) 15
  • Food & Drug Administration (FDA) 12
  • Veterans Affairs, Dept of (VA) 12
  • Defense Threat Reduction Agency (DTRA) 6
 Recent filings 54 total
2T
IPILL, INC.
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $20,000 income · posted Jul 18, 2026
View →
Q2
BULLBAG CORPORATION
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · posted Jul 18, 2026
View →
Q2
CLEARMIND MEDICINE, INC
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $20,000 income · posted Jul 18, 2026
View →
2T
ADIAL PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $10,000 income · posted Jul 18, 2026
View →
Q2
BREAKING BARRIERS TO SUBSTANCE USE RECOVERY
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $10,000 income · posted Jul 18, 2026
View →
Q2
ELSE NUTRITION GH LTD.
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $10,000 income · posted Jul 18, 2026
View →
Q2
THE RECOVERY PLATFORM
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · posted Jul 18, 2026
View →
Q2
RECCE PHARMACEUTICALS LTD
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $20,000 income · posted Jul 18, 2026
View →
Q2
NEXALIN TECHNOLOGY INC.
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $20,000 income · posted Jul 18, 2026
View →
Q1
IPILL, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · posted Apr 20, 2026
View →
RR
IPILL, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 20, 2026
View →
Q1
ADIAL PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $10,000 income · posted Apr 20, 2026
View →
Q1
BULLBAG CORPORATION
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · posted Apr 20, 2026
View →
Q1
CLEARMIND MEDICINE, INC
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $10,000 income · posted Apr 20, 2026
View →
Q1
BREAKING BARRIERS TO SUBSTANCE USE RECOVERY
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $10,000 income · posted Apr 20, 2026
View →
Q1
ELSE NUTRITION GH LTD.
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $10,000 income · posted Apr 20, 2026
View →
Q1
THE RECOVERY PLATFORM
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · posted Apr 20, 2026
View →
Q1
RECCE PHARMACEUTICALS LTD
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $20,000 income · posted Apr 20, 2026
View →
Q1
NEXALIN TECHNOLOGY INC.
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $20,000 income · posted Apr 20, 2026
View →
Q4
BULLBAG CORPORATION
4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · posted Jan 20, 2026
View →

Showing the 20 most recent of 54 filings. Search the explorer for "RK STRATEGIES, INC.".

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem